Evaluation of Decreased Amniotic Fluid Index (Oligohydramnios)

1. Confirm and characterize the finding

• Repeat/verify with a targeted ultrasound: four-quadrant AFI technique or SDP (many centers now prefer SDP <2 cm since it has fewer false positives for intervention than AFI <5 cm).
• Document severity (borderline vs. severe) - this affects surveillance intensity and outcome risk.

2. Focused history and physical exam

• Rule out ruptured membranes first - fluid leakage history, speculum exam, pooling/ferning/nitrazine or a fetal fibronectin/PAMG-1 based ROM test.
• Medication review - ACE inhibitors/ARBs, NSAIDs/indomethacin (decrease fetal urine output).
• Maternal conditions - hypertension/preeclampsia, pregestational or gestational diabetes, dehydration, collagen vascular disease (all linked to uteroplacental insufficiency).
• Gestational age - post-term pregnancy is a common benign cause of physiologic AFV decline.

3. Detailed obstetric ultrasound

• Fetal anatomic survey, focusing on the urinary tract: renal agenesis/dysplasia, multicystic dysplastic kidney, and lower urinary tract obstruction (posterior urethral valves in males) are classic structural causes of markedly reduced fluid from decreased fetal urination - Miller's Anesthesia, p. 4230 (Hydroureter and megacystis/LUTO discussion).
• Fetal growth assessment (EFW) - oligohydramnios is a marker of possible fetal growth restriction from uteroplacental insufficiency.
• Umbilical artery Doppler (± MCA Doppler) if growth restriction is suspected, to assess placental function.
• In monochorionic twins, evaluate for twin-to-twin transfusion syndrome.

4. Further work-up if anomalies or risk factors are found

• Amniocentesis for karyotype/microarray if structural anomalies are seen, and for suspected congenital infection.
• Consider fetal MRI in severe oligohydramnios to better characterize associated anomalies - Miller's Anesthesia, p. 4236.
• Screen for aneuploidy and infections (e.g., rubella, varicella exposure) per routine prenatal protocols if not already completed.

5. Antepartum surveillance once diagnosed

• Increased fetal testing: nonstress tests and/or biophysical profile once or twice weekly (AFI/SDP is itself one of the 5 BPP components) - Pfenninger and Fowler's Procedures for Primary Care, "Fetal Assessment (Biophysical Profile)."
• Serial growth ultrasounds every 2-4 weeks.
• If PPROM-related and preterm, manage per PPROM protocol - a low AFI (<5 cm) in conservatively managed preterm PROM is associated with shorter latency to delivery and higher neonatal morbidity, so it changes counseling and monitoring intensity - Creasy & Resnik's Maternal-Fetal Medicine, p. 1871.

6. Management direction (etiology-dependent)

• Idiopathic isolated oligohydramnios at term: typically increased surveillance ± delivery around 36-37 weeks per ACOG/SMFM timing guidance.
• Structural fetal anomaly (e.g., LUTO): specialist referral for possible in-utero intervention (e.g., vesicoamniotic shunting) and multidisciplinary counseling given high perinatal mortality/renal morbidity.
• Maternal dehydration/medication-related: maternal hydration and discontinuing the offending drug (e.g., NSAID, ACEi/ARB) can improve AFI.
• PPROM: expectant management with monitoring for infection, or delivery depending on gestational age.

Recent evidence worth noting

Acute Febrile Illness with Rising Urea/Creatinine

Key differential diagnoses

• Leptospirosis - the classic cause of febrile illness with AKI. Kidney involvement is almost universal; severe disease (Weil disease) combines jaundice, AKI, and pulmonary hemorrhage. Renal injury is characteristically nonoliguric AKI with hypokalemia (due to tubular Na+/K+-ATPase dysfunction and high fractional excretion of K+), unlike most other causes of AKI - Comprehensive Clinical Nephrology, p. 977 (Leptospirosis).
• Malaria (especially P. falciparum) - AKI from hemolysis, cytoadherence/microvascular sequestration, hypovolemia, and "blackwater fever"; can cause AKI, ARDS, and shock even without cerebral malaria - Harrison's Principles of Internal Medicine, 22e.
• Dengue - AKI from plasma leakage/hypotension, direct viral glomerular injury, hemolysis, or rhabdomyolysis; ranges from mild to severe AKI by AKIN criteria - Brenner and Rector's The Kidney.
• Scrub typhus / rickettsial infection - fever with eschar, can cause AKI via interstitial nephritis.
• Enteric (typhoid) fever, influenza - less commonly cause AKI but are in the differential of tropical acute febrile illness (TAFI).
• A large TAFI-AKI cohort found the underlying causes of AKI to be dengue (~59%), malaria (~20%), influenza (~16%), rickettsial disease (~3%), and leptospirosis (~1.5%), though leptospirosis carries the highest per-case AKI risk.

• Sepsis of any source - prerenal azotemia progressing to acute tubular necrosis (ATN) from hypoperfusion; fever, tachycardia, hypotension, and vasopressor requirement are clues - Goldman-Cecil Medicine, "Prerenal Azotemia/Hypoperfusion."
• Acute pyelonephritis/urosepsis - fever with flank pain, pyuria, positive urine culture.
• Acute interstitial nephritis (drug-induced) - fever, rash, eosinophilia, recent new drug (especially NSAIDs, antibiotics) - Goldman-Cecil Medicine.
• Hemolytic uremic syndrome - fever with diarrhea prodrome, hemolytic anemia, thrombocytopenia, schistocytes.
• Severe dehydration/heat illness with rhabdomyolysis - elevated BUN disproportionate to creatinine initially (prerenal pattern), CK markedly elevated if rhabdomyolysis.
• Snakebite (viperid) envenomation - can cause fever, hemolysis, and AKI in endemic regions.

Evaluation approach

• Exposure: contaminated water/soil, rodents, livestock (leptospirosis); travel to malaria-endemic region, mosquito exposure (malaria, dengue); tick/mite/eschar exposure (rickettsia); new medications (AIN); diarrheal prodrome (HUS); recent surgery/instrumentation, indwelling catheter (urosepsis/sepsis).
• Symptom pattern: myalgia and headache (leptospirosis, dengue), jaundice, oliguria vs. preserved urine output, hemoglobinuria/dark urine ("blackwater," hemolysis, rhabdomyolysis).

• Jaundice, conjunctival suffusion, calf tenderness (leptospirosis); rash with eschar (rickettsia); petechiae/bleeding, hepatomegaly, tourniquet test (dengue); hypotension, altered mentation (sepsis, severe malaria); flank tenderness (pyelonephritis).

• CBC with peripheral smear (thrombocytopenia across most of these; malaria parasites/schistocytes on smear), LFTs (marked elevation with leptospirosis/Weil disease), CPK (rhabdomyolysis), LDH/haptoglobin/bilirubin (hemolysis).
• Renal panel: paired urea and creatinine (a disproportionately elevated BUN relative to creatinine suggests a prerenal/volume-depletion component - Creasy & Resnik's Maternal-Fetal Medicine, p. analogous prerenal pattern discussion), serum electrolytes (hypokalemia is a clue toward leptospirosis).
• Urinalysis: proteinuria, hematuria, pyuria, casts; urine culture if pyelonephritis suspected; FeNa/FeUrea if distinguishing prerenal vs. intrinsic renal injury.
• Specific serology/PCR based on exposure and region: Leptospira IgM/MAT or PCR, malaria smear/rapid antigen test, dengue NS1 antigen/IgM, Weil-Felix or specific rickettsial serology, blood cultures for typhoid/sepsis workup.
• Renal ultrasound to exclude obstruction and assess kidney size/echogenicity.

• Apply KDIGO criteria for AKI staging (based on creatinine rise and urine output) to guide need for renal replacement therapy.

Practical takeaway